According to a recently published report by Brisk Insights, the Global in-Vitro ADME Services Market is expected to grow at the CAGR of 6.23% during 2017-2025. The global in-vitro ADME services market is segmented on the basis of service type and geography. The report on global in-vitro ADME services market (by service type and geography) provides a detailed overview and predictive analysis of the market.

Full report available on In-vitro ADME Services Market: Global Industry Size, Growth, Share and Forecast to 2025 report at http://www.briskinsights.com/report/in-vitro-adme-services-market

Market Insights

Abbreviation for absorption, distribution, metabolism and elimination, ADME is a pharmacological term that describes drug disposition in the human body. Thus, collectively ADME is a set of processes that help in analyzing drug performance on human tissue; in-vitro ADME facilitates this testing while avoiding animal testing and faster drug development. Major factors favoring the growth of in-vitro ADME are improved accuracy and predictability of ADME technology, and growing preference for in-vitro testing as against conventional in-vivo methods.

Based on type of services the global In-Vitro ADME services market is segmented into solution properties, drug absorption & transport, drug metabolism and drug-drug interaction. Among these, drug absorption & transport segment was observed to be have the largest revenue share in 2016. Geographically, the global in-vitro ADME services was dominated by Europe. Major factors contributing to the dominance of Europe market are intensive research and development activities being carried out in the region for rapid drug discovery and development both at commercial and academic levels. In addition, most of the drug discovery processes in Europe are performed on the domestic front, thus leaving later phases of drug development for outsourcing. Furthermore, Asia Pacific and Latin America are anticipated to be the fastest progressing markets for in-vitro ADME services, majorly driven by outsourcing of drug discovery and development processes in the regions.

Scope of the report

1. Global In-vitro ADME Services Market, by Product, 2015–2025 ($ Millon)

1.1. Drug Absorption and Transport
1.2. Solution Properties
1.3. Drug Metabolism
1.4. Drug-Drug Interaction

2. Global In-vitro ADME Services Market, by Geography, 2015-2025 ($ Millon)

2.1. North America
2.1.1. U.S.
2.1.2. Canada
2.2. Europe
2.2.1. U.K.
2.2.2. Germany
2.2.3. Rest of Europe
2.3. Asia Pacific
2.3.1. Japan
2.3.2. China
2.3.3. Rest of Asia Pacific
2.4. Latin America (LATAM)
2.4.1. Brazil
2.4.2. Mexico
2.4.3. Rest of Latin America
2.5. Middle East and Africa (MEA)
2.5.1. GCC
2.5.2. Rest of Middle East and Africa

3. Company Profiles

3.1. Absorption Systems LP
3.2. Aptagen, LLC
3.3. Sigma-Aldrich Co. LLC/ MilliporeSigma
3.4. BioTeSys GmbH
3.5. WuXiAppTec
3.6. Cyprotex PLC
3.7. Centrillion Technology Holdings Ltd.
3.8. Covance, Inc.
3.9. In Vitro ADMET Laboratories, LLC
3.10. TNO
3.11. XenoTech, LLC
3.12. Quest Pharmaceutical Services Holdings LLC
3.13. PharmaronBeijing Company Ltd.
3.14. Quintiles IMS Holdings, Inc.
3.15. Optivia Biotechnology Inc.
3.16. BIOalternatives SAS
3.17. Other Major Players

Request Sample: http://www.briskinsights.com/sample-request/560

About Us

Brisk Insights is a global market research firm. Our insightful analysis is focused on developed and emerging markets. We identify trends and forecast markets with a view to aid businesses identify market opportunities optimize strategies. Our team of 200 analysts’ provides enterprises with strategic insights. Brisk Insights works to help enterprises grow through strategic insights and actionable solutions



Contact Us:

Office 1094

109 Vernon House

Friar Lane

Nottingham

NG1 6DQ

+448081890034 (UK)

[email protected]